chrisvoncsefalvay/vaers-outcomes huggingface dataset:
12Jan was the first dose of the covid vaccine, 18Jan she had a positive covid test; Congestion; Cough; This is a spontaneous report from a contactable consumer via the Pfizer-sponsored program. A 64-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on her right arm, via an unspecified route of administration on 12Jan2021 08:00 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient started to feel symptoms on 16Jan2021 09:00, which is cough and congestion. On 18Jan2021, she tested positive for COVID. She is scheduled for getting her second dose on 09Feb2021. She is calling to question if she should get the second dose since she was diagnosed with COVID. The outcome of the events was unknown.
Pt received vaccine on 11/4 & called on 12/3 to report that his arm was continuing to feel tender & appeared to be swollen.  His MD has been notified.
Patient felt light headed and dizzy after receiving his second dose of Pfizer. His blood pressure was 174/110 and his glucose was 46. After he was given glucose tablets, his glucose was 85. He was picked up by his coworkers and he refused EMS.
This spontaneous report as received from a health care worker refers to an unspecified number of unspecified patients. Patients medical history and current conditions were not reported. On an unknown date since 2-JAN-2015, the patients were vaccinated with unspecified number of improperly stored doses of GARDASIL (lot # K006960 and expiry date 19-FEB-2017) via intramusucular route. No adverse effect reported. Product quality complaint was not reported. The outcome of the event was unknown. This is one of the two reports received from the same reporter. Additional information has been requested.
Developed SARS COV-19 disease.  Runny nose, headache, sore throat.
Seven days after receiving the vaccine, the arm began to scratch, the next day it was red, a little swollen, itchy, about a size of 3.5 cm. To date, the outbreak has not disappeared but the swelling, itching and redness have decreased.
Few things different from before I got my shot; stuff arm; This spontaneous case was reported by an other health care professional and describes the occurrence of FEELING ABNORMAL (Few things different from before I got my shot) and MUSCULOSKELETAL STIFFNESS (stuff arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Few things different from before I got my shot) and MUSCULOSKELETAL STIFFNESS (stuff arm). At the time of the report, FEELING ABNORMAL (Few things different from before I got my shot) and MUSCULOSKELETAL STIFFNESS (stuff arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment drugs were reported. Patient was feeling ok after vaccination.
Numbness in injection arm down to fingernails. Sporadically occurs but mostly at night. Does occur randomly throughout the day.
This employee of the hospital received her TDaP (right) and Hep B (left) vaccines on 7/21/09 around 1530. Awoke in the middle of the night with fever, chills, felt achy all over, and could not lift her right arm that was painful to the touch. The next morning she came on to work at 0700 but throughout the morning developed more flu-like symptoms with progressively worsening all over muscle achiness, increased diffuse muscle achiness. At around 1000, she stood up to stretch and experienced vasovagal syncope with transient loss of consciousness, photophobia, possible fever (tylenol was given 30 min prior to episode however) was very tearful with inconsolable crying present, and very anxious. Code called and employee was shipped to Emergency department. Abnormal ECG and WBC of 16.4 was noted at this time. Given IV NS, ativan 0.5mg IV x2 doses, Zofran 4mg IV, toradol 30mg IV, lortab 5/500mg po x2 tabs. Discharged home from ER with valium 5mg po q8h prn and aleve otc.
Dizziness/lightheadedness; Numbness and tightness in face; Numbness and tightness in face; Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness/lightheadedness), HYPOAESTHESIA (Numbness and tightness in face), SKIN TIGHTNESS (Numbness and tightness in face) and DYSPNOEA (Shortness of breath) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), INSULIN GLARGINE (LANTUS), INSULIN LISPRO (HUMALOG) and BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced DIZZINESS (Dizziness/lightheadedness), HYPOAESTHESIA (Numbness and tightness in face), SKIN TIGHTNESS (Numbness and tightness in face) and DYSPNOEA (Shortness of breath). On 13-Apr-2021, DYSPNOEA (Shortness of breath) had resolved. At the time of the report, DIZZINESS (Dizziness/lightheadedness), HYPOAESTHESIA (Numbness and tightness in face) and SKIN TIGHTNESS (Numbness and tightness in face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Narrative: He relates having experienced a dry/irritated throat that started about 3 hours after the initial vaccination and lasted for about 6-12 hours. The sensation was assisted with water and issues spontaneously resolved. This has not occured with prior vaccinations and he denied any difficulty swallowing, breathing, generalized pruritus, urticaria, flushing, swelling over any part of his body, confusion/disorientation, dizziness/lightheadness, weakness, shortness of breath, palpitations, nausea, abdominal cramping, or feeling the need to vomit/have diarrhea.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On an unknown date in 2013, the patient was inoculated with ZOSTAVAX by a physician as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. On 08-DEC-2014, the patient was treated the same physician for a blistering vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
parent reports infant died 3 days after received vaccines, and that she feels his death was caused by his vaccinations.
1 of 2 pts vaxed form same lot who exp adverse event;pt w/ h/o diabetes & HTN recvd vax 29JUL94; 31JUL had h/a, productive cough, inc resp-32;3AUG & 4AUG clinic visit not feeling well, weak, temp 99.3;rx w/Medrol/solumedrol
Fever up to 103 x 2 days, facial rash 2 days after time onset
pt presents to ED with SOB, chills, weakness, body aches; had a positive COVID test 5 days prior; took ABX and steroids; sx have progressively worsened; admitted to hosp; O2 supplementation; DNI; given Decadron and Remdesivir; pt's condition worsened and he was changed to comfort care; pt passed away in the hospital
There is a oval shaped red mark at the injection site. It is still there as of today (3/9/21)  It is approximately 3 inches long and 1 1/2 inches wide.  There is no pain but the skin in that area is slightly warm to the touch.
tested positive for covid after my first shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for covid after my first shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (tested positive for covid after my first shot). At the time of the report, COVID-19 (tested positive for covid after my first shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment medication was not provided by the reporter.
Red warm area size of half-dollar appeared at injection site at 8:00pm 9-19-16.  9-21-16 site reaction had grown to size of an orange. No pain, but it is warm to touch and itchy. patient marked the outlines and will seek care if uncomfortable or it get worse from here.
Patient initially developed a fever to Tmax 102F. She was seen by urgent care on 6/23/17 and diagnosed with a UTI by dipstick, given ceftriaxone. The next day, 6/24/17, she was noted to have difficulty ambulating and speaking, with a droopy face. She was taken to Medical Center on 6/24/17, and discharged on amoxicillin for presumptive UTI (culture ultimately negative). She was noted to have decreased energy on 6/26/17, seen by PMD, given ceftriaxone and oral meds changed to cephalexin. Patient had received MMR vaccine on 6/2/2017 and had traveled 3 weeks prior to presentation.  She was brought to the ED on 6/27/17, where she was febrile to 100.8F, patient tired appearing, exam benign except for slow ambulation, CT of the head within normal limits, full sepsis workup initiated. CBC with a white count of 20 and LEFT shift neutrophils of 78, stabs 8. CSF Gram stain showed no organisms, CSF WBCs 19, normal glucose and protein. Patient had a brain MRI with and without contrast with bilateral cerebral signal abnormality most prominently affecting both thalami, with focal Left cerebellar white matter involvement. Viral encephalitis and acute disseminated encephalomyelitis were the primary diagnostic considerations. A routine EEG showed intermittent generalized moderate to high amplitude rhythmic slowing. Patient was transferred from inpatient floor to pediatric intensive care unit for hourly neurological checks and intravenous immunoglobulin therapy.
Pain on the arm; High fever 39 C; Tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took ciproflaxacin and experienced drug allergy and  received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient experienced pain on the arm, high fever 39 degree centigrade and tiredness. Therapeutic measures were taken as a result of the events which included treatment with paracetamol. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain on the arm, high fever 39 C and tiredness were resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a certified medical assistant refers to an unspecified number of patients of unknown age and gender. No information on patients' concurrent conditions, medical history or drug allergies was reported. On an unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX (Merck) injection (Lot number L003775 and expiry date 04-FEB-2017) (dosing regimen and route were unknown). No information on patients' concomitant medications was provided. No adverse effects were reported. Lot number L003775 has been verified to be a valid lot number for VARIVAX (Merck). Follow-up information has been received on 03-AUG-2015. All telephone attempts to obtain follow up information had been unsuccessful. Follow-up information has been received on 05-AUG-2015. The Certified Medical Assistant reported that she would have to research the request made for patient identifiers, lot number, expiration date and dates of vaccination. The company tax number was reviewed with the reporter, if information becomes available. Follow-up information has been received from the medical assistant's clinic on 22-OCT-2015. The patient was 12 month old. The patient was vaccinated with improperly stored dose of VARIVAX (Merck) on 28-SEP-2015. This is one of the several reports received from the same reporter. Additional information has been requested. Patient, event, product and narrative information was updated.
Extreme fatigue / exhausted; Sleeping 20 hours a day; Can't focus when I am awake; Can't functioning; Nauseous; My mouth tastes like blood; Throat is sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 28-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Mar2021 15:00 (Batch/Lot number: unknown) at the age of 28 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Covid-19" (unspecified if ongoing), notes: Prior to vaccination, was the patient diagnosed with COVID-19?: Yes. There were no concomitant medications.  The following information was reported: FATIGUE (non-serious) with onset 26Mar2021, outcome "not recovered", described as "Extreme fatigue / exhausted"; HYPERSOMNIA (non-serious) with onset 26Mar2021, outcome "not recovered", described as "Sleeping 20 hours a day"; DISTURBANCE IN ATTENTION (non-serious) with onset 26Mar2021, outcome "not recovered", described as "Can't focus when I am awake"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 26Mar2021, outcome "not recovered", described as "Can't functioning"; NAUSEA (non-serious) with onset 26Mar2021, outcome "not recovered", described as "Nauseous"; TASTE DISORDER (non-serious) with onset 26Mar2021, outcome "not recovered", described as "My mouth tastes like blood"; OROPHARYNGEAL PAIN (non-serious) with onset 26Mar2021, outcome "not recovered", described as "Throat is sore". Therapeutic measures were not taken as a result of fatigue, hypersomnia, disturbance in attention, loss of personal independence in daily activities, nausea, taste disorder, oropharyngeal pain.  Additional Information: It was reported that patient did not receive any other medications received 2 weeks of vaccination and any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, had not tested for COVID-19. There were no known allergies. The patient had been experiencing extreme fatigue since she got the shot, sleeping 20 hours a day and still felt exhausted. She stated that "I am about to lose my job because of you, I cant focus when I am awake because I am exhausted, I cant do my job, I can't functioning, I haven't even been awake long enough to buy food since the 27th. I have pretty much been laying here trying to get as much work done as possible before I fall asleep again. I am nauseous. My mouth tastes like blood. My throat is sore. I would rather be dead. It's been more than 2 weeks. This was only my first shot".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
It WAS A Mix-up ON My VACCiNE.  IN My ChArt ANd the system it SAiD PfiZER I eNded up getting ModerNA. ThursdAy wheN I Awoke I hAd Chills, felt lightheAded NASUSeA, NO Appetite
Got shingles 3 days after second dose of Pfizer vaccine on back of right side of neck. Vaccine was on right arm. Lymph node painfully swollen. Doctor said it was unrelated and stress induced because I have gotten shingles a few times already, though I am not sure because 3 days is very close together.
pt recv vax 15AUG97 & 24AUG97 pt devel a low grade fever & rash just below the shoulders & narrowing down back;rash appears to be prickly heat, red papules erythematous not in a dermatome;
This spontaneous report was received from a registered nurse, referring to a 15 year old non pregnant female patient. The patient's medical history,concurrent conditions or concomitant medication were not reported. On an unknown date in June 2017, the patient was vaccinated with GARDASIL 9 for prophylaxis (dosage information, route, lot number and expiration date were not reported). On an unknown date in "June 2017", the patient "developed a bump at the injection site weeks after administration of GARDASIL 9. The reporter stated that unspecified "months later" "the bump grew larger and larger." Additionally,"unspecified cultures were performed" and came back "negative". Subsequently, on an unspecified date to treat the bump "a debridement of the bump was performed". The outcome of injection site mass was reported as recovered on an unknown date in 2017. The causality assessment between injection site mass and therapy with GARDASIL 9 was not provided.
6 hrs p/MMR vax noted t103.5 associated w/ 20 second generalized tonic-clonic seizure;
COVID; COVID; This is a spontaneous report from a contactable consumer. This report was received via a sales representative.   An elderly female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: not reported), via an unspecified route of administration on an unspecified date, as dose number unknown, single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. After use of Pfizer vaccine on an unknown date, the patient came down with COVID. All of them took the Pfizer vaccine when it became available because they were over 75 years of age. Recently 3 out of the 8 in the group have come down with COVID. Their strain was unknown. Reporter believes all were over 75 years old with co morbidities. The patient underwent lab tests and procedures which included COVID-19 test: positive. event took place after use of product. Outcome of the event was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021873299 Different patients, Same reporter, vaccine, event.;US-PFIZER INC-2021873319 Different patients, Same reporter, vaccine, event.
Shingles pain and rash; fever, chills, severe body aches. Fever, chills and body aches were gone by Sunday, but the pain with shingles and rash continue so far 4 days later.
doctor prescribed her with antibiotic medication for her sinus; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient herself) reported that a female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID VACCINE, formulation: solution for injection, batch/lot number was not reported), via an unspecified route of administration, on 16Mar2021, as single dose for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included cefdinir (CEFDINIR) taken for sinusitis. The patient stated that she got her first dose of the vaccine last 16Mar2021 and was scheduled to get her second dose this 06Apr2021, her doctor prescribed her with antibiotic medication for her sinus -Cefdinir Omnicef (on an unspecified date) and she asked if she could take her second dose of the vaccine if she was taking this medication. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
5JAN95 recvd vax & 8JAN95 fever;13JAN96 rash; 17JAN95 irritability afeb but diffuse 2mm erythematous papules
He had coughing fits just a few hours afterwards along with redness and rash on his belly and under his eye. I notified his pediatrician of this. It did resolve within the next day. We have not given him another shot of this due to fear of what may happen the next time. This was evening time around 5-6 pm when this started.  Just a few short weeks later about 2 weeks after this shot he recieved a raised lymphnode in the right side of his neck that still til this day has not disappeared. I have had multiple look at it including his Pediatrician. All have said it appears normal. Its the size of a pea and recently another lymphnode which is close to the original one beside his jugular vein has appeared. It's below it kind of moving down towards his neck which concerns me. I was already hesitant about vaccines and now what was a once healthy baby has lymphnodes that have popped out of nowhere and keeps an ear infection.
Patient states approximately five days after vaccination developed red painful spot about 1" diameter on right upper forehead; has not progressed or worsened in severity; does not report any itch.  Spot examined at time of report (13 days after immunization) appears consistent with very mild manifestation of Shingles
Fever 104.8 x 1 day. TYLENOL, IV Fluids x 1L
Day 1: left arm hurting, headache, dizzy, eyes hurting, tired Day 2: left arm hurting, tired, legs were weak, feeling not well in general Day 3 - day 7: left arm hurting, got a lump under my armpit (it hurts and bothers), I have a tingling sensation (left arm to my finges, my left chest, my left back), I feel like when you apply Bengay (hot and cold), it feels like this freeze sensation where heart goes, I feel like a pinch on my back. I get trouble breathing (like anxiety, but it's not). I feel my arm tingles like when you're on top of it and it's "asleep".    I'm super scared because these are "known" effects, but it's been 7 days now. Also, I'm super scared because I've heard second dose is when you actually feel sick... if this is the first one, will it get worse on the second one? is it recommended to get second one?
Information has been received from a registered nurse concerning a 13-month-old male with no previous allergies or pertinent medical history who on 23-FEB-2007 was vaccinated subcutaneously with a 0.5 ml dose of Varivax (Lot # 654520/1152F). Concomitant therapy included MMR II. On 13-MAR-2007, the patient experienced chickenpox rash "all over the body" including near the eyes. Unspecified medical attention was sought. No laboratory or diagnostic studies were performed. The outcome was not provided. No additional information to report. There was no product quality complaint involved. Additional information has been requested.
Generalized seizure x 20 seconds. Unknown if fever present at the time of seizures.